EligibleTrials

Investigating the Optimal Management of Dolutegravir Resistance

Recruiting · NCT06762054 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Nairobi

View the official record on ClinicalTrials.gov →
HIV

Interventions studied

Continue DTG-based antiretroviral therapyEnhanced adherence counselling

What this trial is about

The goal of this study is to address the gap in published data on viral suppression among people meeting the criteria for virologic failure on dolutegravir (DTG)-based ART regimens without a change in regimen. The study will also assess the emergence of DTG-associated drug-resistant mutations and their impact on viral suppression.

Who can take part

Age range
1 Year and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

9 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.